Quick Answer
NOVAVAX INC reported Stockholders Equity of -$127.75 million for the year ending 2025.
- NOVAVAX INC showed an increase of +79.5% in Stockholders Equity from 2024 to 2025.
- This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $61.08 million | Q3 2012: $61.38 million | Q1 2013: $77.57 million | Q2 2013: $69.23 million | Q3 2013: $216.57 million | Q1 2014: $191.06 million | Q2 2014: $281.73 million | Q3 2014: $261.65 million | Q1 2015: $399.71 million | Q2 2015: $387.60 million | Q3 2015: $367.02 million | Q1 2016: $185.43 million | Q2 2016: $110.12 million | Q3 2016: $49.78 million | Q1 2017: -$29.10 million | Q2 2017: -$59.06 million | Q3 2017: -$74.15 million | Q1 2018: -$99.37 million | Q2 2018: -$87.71 million | Q3 2018: -$126.68 million | Q1 2019: -$150.58 million | Q2 2019: -$185.49 million | Q3 2019: -$189.84 million | Q1 2020: -$23.97 million | Q2 2020: $184.53 million | Q3 2020: $106.44 million | Q1 2021: $1.04 billion | Q2 2021: $745.56 million | Q3 2021: $461.34 million | Q1 2022: $65.32 million | Q2 2022: -$416.95 million | Q3 2022: -$565.99 million | Q1 2023: -$895.58 million | Q2 2023: -$754.52 million | Q3 2023: -$678.35 million | Q1 2024: -$867.08 million | Q2 2024: -$431.71 million | Q3 2024: -$526.44 million | Q1 2025: -$75.64 million | Q2 2025: $37.63 million | Q3 2025: -$156.67 million.
- Over the full 14 years of available data (2012 to 2025), NOVAVAX INC's Stockholders Equity has declined by 259.2%.
- Historical annual values: Fiscal year 2025: -$127.75 million | Fiscal year 2024: -$623.84 million | Fiscal year 2023: -$716.93 million | Fiscal year 2022: -$634.08 million | Fiscal year 2021: -$351.67 million | Fiscal year 2020: $627.21 million | Fiscal year 2019: -$186.02 million | Fiscal year 2018: -$167.94 million | Fiscal year 2017: -$101.73 million | Fiscal year 2016: -$5.55 million | Fiscal year 2015: $292.67 million | Fiscal year 2014: $229.62 million | Fiscal year 2013: $203.23 million | Fiscal year 2012: $80.24 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: